Adult Migraine Study
This clinical trial aims to assess the effectiveness of a new preventive treatment for adults suffering from episodic migraines. The study focuses on reducing the frequency and severity of migraine attacks to enhance daily functioning.
ELIGIBILITY CRITERIA
We are seeking participants who meet the following criteria:
- Diagnosed with episodic migraines (4-14 migraine days per month).
- History of migraines for at least one year.
Study Details
Participants will receive the investigational preventive treatment and will be required to maintain a headache diary to record migraine occurrences and severity. Regular clinic visits will include neurological evaluations and assessments of the treatment’s impact on quality of life.
This paid clinical trial offers compensation for participation, providing an opportunity to contribute to migraine research while earning money.
Do you meet the criteria and want to join the study?
If your child meets the criteria and you are interested in contributing to this important research, they may qualify for this study. For more information or to discuss eligibility, please contact the Haltha team at Haltha Connect.
Take part in live studyUnlock Exclusive Content by Subscribing to Our Updates
Stay informed about the latest advancements, breakthroughs, and trends in medical research
